Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 3226-3230, August 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rozhin, J.
Right arrow Articles by Nigro, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rozhin, J.
Right arrow Articles by Nigro, N. D.

Ornithine Decarboxylase Activity in the Rat and Human Colon1

Jurij Rozhin, Paulette S. Wilson, Arthur W. Bull and Norman D. Nigro2

Department of Surgery, Wayne State University School of Medicine, Detroit, Michigan 48201

We have investigated the effect of age, a high-fat diet, sodium deoxycholate, and the ornithine analogue {alpha}-difluoromethylornithine on ornithine decarboxylase (ODC) activity in the rat colon. The relative levels of ODC activity were also determined in normal mucosa and tumor tissue from rat and human colon.

The colonic ODC activity induced by intrarectal instillation of sodium deoxycholate in male Sprague-Dawley rats was highest in young animals, and it decreased with increasing age. A high level of dietary fat caused both an increase in basal colonic ODC activity and enhanced ODC induction by deoxycholate. {alpha}-Difluoromethylornithine given in drinking water inhibited, in a dose-dependent fashion, deoxycholate-induced ODC activity. The frequency of azoxymethane-induced intestinal tumors was also significantly reduced by {alpha}-difluoromethylornithine.

Since colonic ODC activity is increased in carcinogenesis by known promoting agents and decreased by tumor inhibitors, this short-term assay may provide a useful system for identifying colon tumor promoters and inhibitors. The ODC activity in colon tumors of Sprague-Dawley rats was found to be significantly higher than in normal-appearing mucosa in the same animals. Similarly, ODC activity in human colon cancer was found to be higher than that of the normal-appearing mucosa in the same specimen. These results strengthen the utilization of the rat model for studies, the results of which may apply to the human situation.

1 Supported by the Matilda R. Wilson Fund, the James and Lynelle Holden Fund, and individual private contributions. Reported in part at the National Large Bowel Cancer Project Workshop, Houston, TX, June 1983.

2 To whom requests for reprints should be addressed, at Department of Surgery, Wayne State University School of Medicine, 540 E. Canfield, Detroit, MI.

Received 4/19/83. Accepted 4/26/84.




This article has been cited by other articles:


Home page
CA Cancer J ClinHome page
R. F. Souza and S. J. Spechler
Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach
CA Cancer J Clin, November 1, 2005; 55(6): 334 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Sun, A. Wollin, and A. M. Stephen
Moderate Folate Deficiency Influences Polyamine Synthesis in Rats
J. Nutr., September 1, 2002; 132(9): 2632 - 2637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Han, M. N. Kazarinoff, N. Seiler, and B. A. Stanley
Rat colon ornithine and arginine metabolism: coordinated effects after proliferative stimuli
Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G389 - G399.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. L. Meyskens Jr. and E. W. Gerner
Development of Difluoromethylornithine (DFMO) as a Chemoprevention Agent
Clin. Cancer Res., May 1, 1999; 5(5): 945 - 951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.